John Russell
Family Medicine · Jenkintown, PANPI 1336171206
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (53.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. 7 manufacturers reported payments, led by Sanofi Pasteur Inc. at 50.3% of the total. Reporting peaked in 2022 at $18,562 and has fallen 91.2% since, to $1,635 in 2025. Among family medicine clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 85 payments — averaging $963.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi Pasteur Inc.$41K
- Pfizer$33K
- GSK$7K
- Bayer$1K
- Merck$111
- Sumitomo Pharma America, Inc.$53
- plus $21 from 1 others
What the payments were for
- Consulting fees$31,77039%
- Speaking & faculty fees$44,05454%
- Travel & lodging$4,7726%
- Food & beverage$1,3132%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi Pasteur Inc. | 52 | $41,219 |
| Pfizer | 20 | $32,740 |
| GSK | 8 | $6,731 |
| Bayer | 1 | $1,033 |
| Merck | 1 | $111 |
| Sumitomo Pharma America, Inc. | 2 | $53 |
| Modernatx, Inc. | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FLUZONE HIGH-DOSE$22,400
- FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE$10,707
- ABRYSVO$10,584
- EUCRISA$7,900
- FLUZONE QUADRIVALENT$6,226
- FLUBLOK QUADRIVALENT$4,680
- MENACYW CONJUGATE VACCINE$4,680
- MENQUADFI$4,061
- PREVNAR 20$2,975
- TRELEGY ELLIPTA$2,555
- NUCALA$2,190
- Non-Covered$1,033
- ADACEL$963
- NO PRODUCT DISCUSSED$733
- ANORO ELLIPTA$730
- BEXSERO$125
- GARDASIL$111
How this compares
$81,908 in reported general payments places this provider in the 95th percentile of 4,967 family medicine providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 18 | $22,869 |
| WegovySemaglutide | 12 | $17,105 |
| Spiriva HandihalerTiotropium Bromide | 15 | $10,211 |
| SymbicortBudesonide/Formoterol Fumarate | 12 | $2,598 |
| Atorvastatin Calcium | 145 | $1,852 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 11 | $1,315 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 11 | $1,083 |
| Losartan Potassium | 65 | $965 |
| Rosuvastatin Calcium | 20 | $917 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 32 | $914 |
| Simvastatin | 44 | $858 |
| Metformin Hcl | 49 | $848 |
| Lisinopril | 72 | $747 |
| Oxycodone Hcl | 16 | $738 |
| Easy Touch Pen NeedlePen Needle, Diabetic | 14 | $737 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Jenkintown
- Neil SkolnikJenkintown$904K
- Lisa EspinozaNew Hope$722K
- Christopher Varacallodu Bois$627K
- Paul DoghramjiCollegeville$617K
- Brian DeyarminBethel Park$491K
- Nathan BennettPittsburgh$465K
- Gary OwensGlen Mills$404K
- Mary ZakutneyIrwin$393K
- H WilkinsSellersville$380K
- Deborah WittPhiladelphia$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.